ZIP9 Is a Druggable Determinant of Sex Differences in Melanoma
Open Access
- 27 October 2021
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 81 (23) , 5991-6003
Abstract
Melanoma and most other cancers occur more frequently and have worse prognosis in males compared with females. Although sex steroids are thought to be involved, classical androgen and estrogen receptors are not detectable in most melanomas. Here we show that testosterone promotes melanoma proliferation by activating ZIP9 (SLC39A9), a zinc transporter that is widely expressed in human melanoma but not intentionally targeted by available therapeutics. This testosterone activity required an influx of zinc, activation of MAPK, and nuclear translocation of YAP. FDA-approved inhibitors of the classical androgen receptor also inhibited ZIP9, thereby antagonizing the protumorigenic effects of testosterone in melanoma. In male mice, androgen receptor inhibitors suppressed growth of ZIP9-expressing melanomas but had no effect on isogenic melanomas lacking ZIP9 or on melanomas in females. These data suggest that ZIP9 might be effectively targeted in melanoma and other cancers by repurposing androgen receptor inhibitors that are currently approved only for prostate cancer. Significance: Testosterone signaling through ZIP9 mediates some of the sex differences in melanoma, and drugs that target AR can be repurposed to block ZIP9 and inhibit melanoma in males.Keywords
All Related Versions
Funding Information
- NIH
- NCI (R01 CA163566, R41CA228695)
- Dermatology Foundation
- Penn Skin Biology and Diseases Resource-based Center (P30-AR069589)
- Melanoma Research Foundation
- U.S. Department of War (W81XWH2110860)
This publication has 41 references indexed in Scilit:
- Exploration of a new drug that targets YAPThe Journal of Biochemistry, 2012
- Clinical implication of 14-3-3 epsilon expression in gastric cancerWorld Journal of Gastroenterology, 2012
- Hormonal and reproductive factors in relation to melanoma in women: Current review and meta-analysisEuropean Journal of Cancer, 2011
- Novel evidence that testosterone promotes cell proliferation and differentiation via G protein‐coupled receptors in the rat L6 skeletal muscle myoblast cell lineJournal of Cellular Physiology, 2011
- Molecular and genetic features of zinc transporters in physiology and pathogenesisMetallomics, 2011
- A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCFβ-TRCPGenes & Development, 2010
- SLC39A9 (ZIP9) Regulates Zinc Homeostasis in the Secretory Pathway: Characterization of the ZIP Subfamily I Protein in Vertebrate CellsBioscience, Biotechnology, and Biochemistry, 2009
- ZIP8, Member of the Solute-Carrier-39 (SLC39) Metal-Transporter Family: Characterization of Transporter PropertiesMolecular Pharmacology, 2006
- Chemistry and Structural Biology of Androgen ReceptorChemical Reviews, 2005
- Androgen receptors, androgen‐dependent proliferation, and 5α‐reductase activity of small‐cell lung cancer cell linesInternational Journal of Cancer, 1989